A New Measure of Child-Reported Symptomatic Toxicities of Cancer Treatment: Introducing Pediatric PRO-CTCAE®
Purpose
NCI’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) was developed to capture symptomatic toxicity by patient self-report in cancer clinical trials. A pediatric version of PRO-CTCAE (Ped-PRO-CTCAE®) is now available to enable self-reporting of symptomatic adverse events by children and adolescents.
In this webinar speakers and discussants
- Describe the design and psychometric testing of Ped-PRO-CTCAE®
- Demonstrate the creation of customized PRO-CTCAE® surveys
- Highlight the value of this new measure for pediatric oncology trials
Intended Audience
Extramural investigators at junior, mid, and senior levels.
Suggested Readings
- Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Am Soc Clin Oncol Educ Book 2016;35:67-73. doi: 10.14694/EDBK_159514
- Reeve BB et al. Pediatr Blood and Cancer 2017;64(3):1-7. DOI: 10.1002/pbc.26261.
- Reeve BB et al. JNCI. Published online first. https://doi.org/10.1093/jnci/djaa016
Presenters
![Pamela S. Hinds](/images/webinars/hindsp.jpg)
Pamela S. Hinds, PhD, RN, FAAN
Children's National Hospital
![Molly McFatrich](/images/webinars/mcfatrichm.jpg)
Molly McFatrich, MPH
Duke University School of Medicine
![Bryce B. Reeve](/images/webinars/reeveb.jpg)
Bryce B. Reeve, PhD
Duke University School of Medicine
Discussants
![David R. Freyer](/images/webinars/freyerd.jpg)
David R. Freyer, DO, MS
Children's Hospital Los Angeles
USC Norris Comprehensive Cancer Center
![Gregory H. Reaman](/images/webinars/reamang.jpg)
Gregory H. Reaman, MD
U.S. Food & Drug Administration
![](/images/webinars/hawkinsd.jpg)
Douglas S. Hawkins, MD
Seattle Children's Hospital
Moderator
![Sandra A. Mitchell](/images/webinars/mitchell.jpg)
Sandra A. Mitchell, PhD, CRNP, FAAN
National Cancer Institute
This webinar will be archived on the HDRP Events webpage.